Modifier Description   Effective
CLAt least 60 percent but less than 80 percent impaired, limited or restrictedJan 01, 2013
CMAt least 80 percent but less than 100 percent impaired, limited or restrictedJan 01, 2013
CN100 percent impaired, limited or restrictedJan 01, 2013
COOutpatient occupational therapy services furnished in whole or in part by an occupational therapy assistant Jan 01, 2019
CPAdjunctive service related to a procedure assigned to a comprehensive ambulatory payment classification (c-apc) procedure, but reported on a different claim Jan 01, 2018
CQOutpatient physical therapy services furnished in whole or in part by a physical therapist assistant Jan 01, 2019
CRCatastrophe/disaster relatedAug 21, 2005
CSCost-sharing waived for specified covid-19 testing-related services that result in and order for or administration of a covid-19 test and/or used for cost-sharing waived preventive services furnished via telehealth in rural health clinics and federally qualified health centers during the covid-19 public health emergency Mar 01, 2020
CTComputed tomography services furnished using equipment that does not meet each of the attributes of the national electrical manufacturers association (nema) xr-29-2013 standard Jan 01, 2016
DAOral health assessment by a licensed health professional other than a dentistJan 01, 2011
E1Upper left, eyelidJan 01, 1999
E2Lower left, eyelidJan 01, 1999
E3Upper right, eyelidJan 01, 1999
E4Lower right, eyelidJan 01, 1999
EAErythropoietic stimulating agent (esa) administered to treat anemia due to anti-cancer chemotherapy Jan 01, 2008
EBErythropoietic stimulating agent (esa) administered to treat anemia due to anti-cancer radiotherapy Jan 01, 2008
ECErythropoietic stimulating agent (esa) administered to treat anemia not due to anti-cancer radiotherapy or anti-cancer chemotherapy Jan 01, 2008
EDHematocrit level has exceeded 39% (or hemoglobin level has exceeded 13.0 g/dl) for 3 or more consecutive billing cycles immediately prior to and including the current cycle Jan 01, 2008
EEHematocrit level has not exceeded 39% (or hemoglobin level has not exceeded 13.0 g/dl) for 3 or more consecutive billing cycles immediately prior to and including the current cycle Jan 01, 2008
EJSubsequent claims for a defined course of therapy, e.g., epo, sodium hyaluronate, infliximab Jan 01, 2000
EMEmergency reserve supply (for esrd benefit only)Jan 01, 1997
EPService provided as part of medicaid early periodic screening diagnosis and treatment (epsdt) program Jan 01, 1997
ERItems and services furnished by a provider-based, off-campus emergency department Jan 01, 2019
ETEmergency servicesJan 01, 2002
EXExpatriate beneficiaryApr 01, 2015